Location: New York, NY
CIK: 0001839435 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Feb 17, 2026
Total Value: $824M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ABVX | ABIVAX SA | 756,000 | $102M | 12.4% | $9.73 | — | SPONSORED ADS | 00370M103 |
| DNTH | DIANTHUS THERAPEUTICS INC | 2,416,667 | $99.59M | 12.1% | $20.69 | +87.4% | COM | 252828108 |
| COGT | COGENT BIOSCIENCES INC | 2,350,000 | $83.47M | 10.1% | $9.93 | +183.0% | COM | 19240Q201 |
| TSHA | TAYSHA GENE THERAPIES INC | 8,859,911 | $48.73M | 5.9% | $2.19 | +122.2% | COM SHS | 877619106 |
| GOSS | GOSSAMER BIO INC | 13,915,371 | $43.14M | 5.2% | $1.89 | +50.7% | COM | 38341P102 |
| KYMR | KYMERA THERAPEUTICS INC | 535,000 | $41.63M | 5.1% | $47.13 | +43.3% | COM | 501575104 |
| AVBP | ARRIVENT BIOPHARMA INC | 1,971,054 | $39.66M | 4.8% | $20.71 | +0.5% | COM | 04272N102 |
| TRVI | TREVI THERAPEUTICS INC | 2,815,000 | $35.24M | 4.3% | $4.91 | +135.5% | COM | 89532M101 |
| OCUL | OCULAR THERAPEUTIX INC | 2,623,600 | $31.85M | 3.9% | $7.47 | +62.7% | COM | 67576A100 |
| — | MIND MEDICINE MINDMED INC | 2,230,000 | $29.86M | 3.6% | $8.56 | — | COM NEW | 60255C885 |
| CGON | CG ONCOLOGY INC | 600,000 | $24.91M | 3.0% | — | — | Call | 156944100 |
| ALMS | ALUMIS INC | 2,530,700 | $24.7M | 3.0% | $6.98 | 0.0% | COM | 022307102 |
| PALI | PALISADE BIO INC | 9,567,898 | $22.48M | 2.7% | $1.92 | 0.0% | COM | 696389402 |
| — | CIDARA THERAPEUTICS INC | 100,000 | $22.09M | 2.7% | $95.76 | — | COM NEW | 171757206 |
| BIOA | BIOAGE LABS INC | 1,598,000 | $21.14M | 2.6% | $8.86 | 0.0% | COM | 09077V100 |
| KALV | KALVISTA PHARMACEUTICALS INC | 1,273,333 | $20.56M | 2.5% | $10.36 | +27.9% | COM | 483497103 |
| RAPT | RAPT THERAPEUTICS INC | 574,000 | $19.44M | 2.4% | $31.06 | 0.0% | COM NEW | 75382E208 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 750,000 | $18.76M | 2.3% | $7.34 | — | SPONSORED ADS | 152309100 |
| PHVS | PHARVARIS N V | 671,465 | $18.63M | 2.3% | $18.98 | +26.9% | COM | N69605108 |
| LXEO | LEXEO THERAPEUTICS INC | 1,725,000 | $17.13M | 2.1% | $9.13 | 0.0% | COM | 52886X107 |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | 1,043,110 | $13.06M | 1.6% | $11.58 | — | COM NEW | 107924102 |
| DBVT | DBV TECHNOLOGIES S A | 574,200 | $11.01M | 1.3% | $9.15 | — | SPONSORED ADS | 23306J309 |
| EVMN | EVOMMUNE INC | 500,000 | $8.56M | 1.0% | $18.78 | 0.0% | COM SHS | 30054Y107 |
| DTIL | PRECISION BIOSCIENCES INC | 1,917,995 | $7.979M | 1.0% | $5.68 | 0.0% | COM NEW | 74019P207 |
| CRBP | CORBUS PHARMACEUTICALS HLDGS | 955,000 | $7.774M | 0.9% | $40.87 | -69.8% | COM NEW | 21833P301 |
| UNCY | UNICYCIVE THERAPEUTICS INC | 1,000,000 | $5.77M | 0.7% | $6.18 | -13.7% | COM NEW | 90466Y202 |
| PEPG | PEPGEN INC | 700,000 | $4.557M | 0.6% | $1.61 | +222.0% | COM | 713317105 |